These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34253022)

  • 21. Identifying the Template for Oligomer to Fibril Conversion for Amyloid-β (1-42) Oligomers using Hamiltonian Replica Exchange Molecular Dynamics.
    Saha D; Jana B
    Chemphyschem; 2022 Dec; 23(24):e202200393. PubMed ID: 36052514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced stability of a disaggregated Aβ fibril on removal of ligand inhibits refibrillation: An all atom Molecular Dynamics simulation study.
    Gupta S; Dasmahapatra AK
    Int J Biol Macromol; 2023 Jun; 240():124481. PubMed ID: 37076062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and Fractionation of Heterogeneous Aβ42 Oligomers with Different Aggregation Properties.
    Chen EW; Guo Z
    Methods Mol Biol; 2023; 2551():29-39. PubMed ID: 36310194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.
    Ghosh P; Kumar A; Datta B; Rangachari V
    BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S24. PubMed ID: 20946608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphic structures of Alzheimer's β-amyloid globulomers.
    Yu X; Zheng J
    PLoS One; 2011; 6(6):e20575. PubMed ID: 21687730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain.
    Zhong X; Kumar R; Wang Y; Biverstål H; Ingeborg Jegerschöld C; J B Koeck P; Johansson J; Abelein A; Chen G
    ACS Chem Biol; 2022 Aug; 17(8):2201-2211. PubMed ID: 35876740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.
    Wu JW; Breydo L; Isas JM; Lee J; Kuznetsov YG; Langen R; Glabe C
    J Biol Chem; 2010 Feb; 285(9):6071-9. PubMed ID: 20018889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular dynamics simulations to investigate the structural stability and aggregation behavior of the GGVVIA oligomers derived from amyloid beta peptide.
    Chang LK; Zhao JH; Liu HL; Liu KT; Chen JT; Tsai WB; Ho Y
    J Biomol Struct Dyn; 2009 Jun; 26(6):731-40. PubMed ID: 19385701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracking the mechanism of fibril assembly by simulated two-dimensional ultraviolet spectroscopy.
    Lam AR; Rodriguez JJ; Rojas A; Scheraga HA; Mukamel S
    J Phys Chem A; 2013 Jan; 117(2):342-50. PubMed ID: 23214934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific keratinase derived designer peptides potently inhibit A
    Rajput R; G L B; Srivastava A; Wahi D; Shrivastava N; Kundu B; Grover A
    Biochem J; 2019 Jun; 476(12):1817-1841. PubMed ID: 31138770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
    Sharoar MG; Thapa A; Shahnawaz M; Ramasamy VS; Woo ER; Shin SY; Park IS
    J Biomed Sci; 2012 Dec; 19(1):104. PubMed ID: 23259691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of K16A and K28A mutation on the structure and dynamics of amyloid-β
    Shuaib S; Saini RK; Goyal D; Goyal B
    J Biomol Struct Dyn; 2020 Feb; 38(3):708-721. PubMed ID: 30821624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular dynamics simulations to investigate the aggregation behaviors of the Abeta(17-42) oligomers.
    Zhao JH; Liu HL; Liu YF; Lin HY; Fang HW; Ho Y; Tsai WB
    J Biomol Struct Dyn; 2009 Feb; 26(4):481-90. PubMed ID: 19108587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidating Important Sites and the Mechanism for Amyloid Fibril Formation by Coarse-Grained Molecular Dynamics.
    Rojas A; Maisuradze N; Kachlishvili K; Scheraga HA; Maisuradze GG
    ACS Chem Neurosci; 2017 Jan; 8(1):201-209. PubMed ID: 28095675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic and thermodynamic stability comparison for the fibrillar form of small amyloid-β(1-42) oligomers using scaled molecular dynamics.
    Saha D; Jana B
    Phys Chem Chem Phys; 2021 Aug; 23(31):16897-16908. PubMed ID: 34328153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico and in vitro studies to elucidate the role of Cu2+ and galanthamine as the limiting step in the amyloid beta (1-42) fibrillation process.
    Hernández-Rodríguez M; Correa-Basurto J; Benitez-Cardoza CG; Resendiz-Albor AA; Rosales-Hernández MC
    Protein Sci; 2013 Oct; 22(10):1320-35. PubMed ID: 23904252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides.
    Bruce NJ; Chen D; Dastidar SG; Marks GE; Schein CH; Bryce RA
    Peptides; 2010 Nov; 31(11):2100-8. PubMed ID: 20691234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Mechanism and Kinetics of Amyloid-β
    Man VH; He X; Ji B; Liu S; Xie XQ; Wang J
    ACS Chem Neurosci; 2019 Nov; 10(11):4643-4658. PubMed ID: 31660732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.